BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stout M, Tew GA, Doll H, Zwierska I, Woodroofe N, Channer KS, Saxton JM. Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: a double-blind randomized controlled feasibility study. Am Heart J 2012;164:893-901. [PMID: 23194490 DOI: 10.1016/j.ahj.2012.09.016] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 6.9] [Reference Citation Analysis]
Number Citing Articles
1 Isidori AM, Aversa A, Calogero A, Ferlin A, Francavilla S, Lanfranco F, Pivonello R, Rochira V, Corona G, Maggi M. Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE). J Endocrinol Invest 2022. [PMID: 36018454 DOI: 10.1007/s40618-022-01859-7] [Reference Citation Analysis]
2 Di Lodovico E, Facondo P, Delbarba A, Pezzaioli LC, Maffezzoni F, Cappelli C, Ferlin A. Testosterone, Hypogonadism, and Heart Failure. Circ Heart Fail 2022;15:e008755. [PMID: 35392658 DOI: 10.1161/CIRCHEARTFAILURE.121.008755] [Reference Citation Analysis]
3 Napoli R, D’assante R, Miniero M, Salzano A, Cittadini A. Anabolic Deficiencies in Heart Failure. Cardiology Clinics 2022;40:149-59. [DOI: 10.1016/j.ccl.2021.12.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Valentova M, Anker SD, von Haehling S. Cardiac Cachexia Revisited. Cardiology Clinics 2022;40:199-207. [DOI: 10.1016/j.ccl.2021.12.008] [Reference Citation Analysis]
5 Auerbach JM, Khera M. Testosterone replacement therapy and cardiovascular disease. Int J Impot Res 2022. [PMID: 34999717 DOI: 10.1038/s41443-021-00516-6] [Reference Citation Analysis]
6 Fernández-Pombo A, Rodríguez-Carnero G, Castro AI, Cantón-Blanco A, Seoane LM, Casanueva FF, Crujeiras AB, Martínez-Olmos MA. Relevance of nutritional assessment and treatment to counteract cardiac cachexia and sarcopenia in chronic heart failure. Clin Nutr 2021;40:5141-55. [PMID: 34461588 DOI: 10.1016/j.clnu.2021.07.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhang X, Zhao H, Horney J, Johnson N, Saad F, Haider KS, Haider A, Xu X. Testosterone Deficiency, Long-Term Testosterone Therapy, and Inflammation. J Cardiovasc Pharmacol Ther 2021;:10742484211032402. [PMID: 34247541 DOI: 10.1177/10742484211032402] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Harwood AE, Russell S, Okwose NC, McGuire S, Jakovljevic DG, McGregor G. A systematic review of rehabilitation in chronic heart failure: evaluating the reporting of exercise interventions. ESC Heart Fail 2021. [PMID: 34235878 DOI: 10.1002/ehf2.13498] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Falqueto H, Júnior JLR, Silvério MNO, Farias JCH, Schoenfeld BJ, Manfredi LH. Can conditions of skeletal muscle loss be improved by combining exercise with anabolic-androgenic steroids? A systematic review and meta-analysis of testosterone-based interventions. Rev Endocr Metab Disord 2021;22:161-78. [PMID: 33783694 DOI: 10.1007/s11154-021-09634-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
10 Cannarella R, Calogero AE, Condorelli RA, Aversa A, La Vignera S. Systemic effects of the hormonal treatment of male hypogonadism with preliminary indications for the management of COVID-19 patients. Ther Adv Endocrinol Metab 2020;11:2042018820966438. [PMID: 33133492 DOI: 10.1177/2042018820966438] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Li W, Yue T, Liu Y. New understanding of the pathogenesis and treatment of stroke-related sarcopenia. Biomedicine & Pharmacotherapy 2020;131:110721. [DOI: 10.1016/j.biopha.2020.110721] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
12 Matsumura K, Teranaka W, Matsumoto H, Fujii K, Tsujimoto S, Otagaki M, Morishita S, Hashimoto K, Shibutani H, Yamamoto Y, Shiojima I. Loss of skeletal muscle mass predicts cardiac death in heart failure with a preserved ejection fraction but not heart failure with a reduced ejection fraction. ESC Heart Fail 2020. [PMID: 32964678 DOI: 10.1002/ehf2.13021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Park S, Gale SE, Watson K. The Role of Testosterone in Patients With Heart Failure: A Systematic Review. Cardiol Rev 2021;29:156-61. [PMID: 32947484 DOI: 10.1097/CRD.0000000000000350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Auerbach JM, Khera M. Hypogonadism management and cardiovascular health. Postgrad Med 2020;132:35-41. [PMID: 32799602 DOI: 10.1080/00325481.2020.1805917] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Murphy L, Gray A, Joyce E. Anabolism to Catabolism: Serologic Clues to Nutritional Status in Heart Failure. Curr Heart Fail Rep 2019;16:189-200. [PMID: 31606846 DOI: 10.1007/s11897-019-00437-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
16 Peng X, Gao L, Aibai S. Antifatigue effects of anshenyizhi compound in acute excise‐treated mouse via modulation of AMPK/PGC‐1α‐related energy metabolism and Nrf2/ARE‐mediated oxidative stress. Journal of Food Science 2020;85:1897-906. [DOI: 10.1111/1750-3841.15149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
17 Tao J, Liu X, Bai W. Testosterone Supplementation in Patients With Chronic Heart Failure: A Meta-Analysis of Randomized Controlled Trials. Front Endocrinol (Lausanne) 2020;11:110. [PMID: 32231640 DOI: 10.3389/fendo.2020.00110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
18 Zhang Z, Kang D, Li H. The effects of testosterone on bone health in males with testosterone deficiency: a systematic review and meta-analysis. BMC Endocr Disord 2020;20:33. [PMID: 32145741 DOI: 10.1186/s12902-020-0509-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
19 Walther A, Breidenstein J, Miller R. Association of Testosterone Treatment With Alleviation of Depressive Symptoms in Men: A Systematic Review and Meta-analysis. JAMA Psychiatry 2019;76:31-40. [PMID: 30427999 DOI: 10.1001/jamapsychiatry.2018.2734] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 26.0] [Reference Citation Analysis]
20 Napoli R, D’assante R, Miniero M, Salzano A, Cittadini A. Anabolic Deficiencies in Heart Failure. Heart Failure Clinics 2020;16:11-21. [DOI: 10.1016/j.hfc.2019.08.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Valentova M, Anker SD, von Haehling S. Cardiac Cachexia Revisited. Heart Failure Clinics 2020;16:61-9. [DOI: 10.1016/j.hfc.2019.08.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
22 Fatima M, Brennan-Olsen SL, Duque G. Therapeutic approaches to osteosarcopenia: insights for the clinician. Ther Adv Musculoskelet Dis 2019;11:1759720X19867009. [PMID: 31431811 DOI: 10.1177/1759720X19867009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
23 Corona G, Rastrelli G, Guaraldi F, Tortorici G, Reismann Y, Sforza A, Maggi M. An update on heart disease risk associated with testosterone boosting medications. Expert Opin Drug Saf 2019;18:321-32. [PMID: 30998433 DOI: 10.1080/14740338.2019.1607290] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
24 Salzano A, D'Assante R, Lander M, Arcopinto M, Bossone E, Suzuki T, Cittadini A. Hormonal Replacement Therapy in Heart Failure: Focus on Growth Hormone and Testosterone. Heart Fail Clin 2019;15:377-91. [PMID: 31079696 DOI: 10.1016/j.hfc.2019.02.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
25 Traustadóttir T, Harman SM, Tsitouras P, Pencina KM, Li Z, Travison TG, Eder R, Miciek R, McKinnon J, Woodbury E, Basaria S, Bhasin S, Storer TW. Long-Term Testosterone Supplementation in Older Men Attenuates Age-Related Decline in Aerobic Capacity. J Clin Endocrinol Metab 2018;103:2861-9. [PMID: 29846604 DOI: 10.1210/jc.2017-01902] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
26 Bianchi VE. Testosterone, myocardial function, and mortality. Heart Fail Rev 2018;23:773-88. [PMID: 29978359 DOI: 10.1007/s10741-018-9721-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
27 Pencina KM, Travison TG, Bhasin S, Li Z, Nigam N, Manning WJ, Vasan RS, Hoffmann U, O'Donnell CJ, Basaria S. Endogenous circulating testosterone and sex hormone-binding globulin levels and measures of myocardial structure and function: the Framingham Heart Study. Andrology 2019;7:307-14. [PMID: 30761772 DOI: 10.1111/andr.12590] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
28 Navarro-Peñalver M, Perez-Martinez MT, Gómez-Bueno M, García-Pavía P, Lupón-Rosés J, Roig-Minguell E, Comin-Colet J, Bayes-Genis A, Noguera JA, Pascual-Figal DA. Testosterone Replacement Therapy in Deficient Patients With Chronic Heart Failure: A Randomized Double-Blind Controlled Pilot Study. J Cardiovasc Pharmacol Ther 2018;23:543-50. [PMID: 29929385 DOI: 10.1177/1074248418784020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
29 Bianchi VE, Locatelli V. Testosterone a key factor in gender related metabolic syndrome: Testosterone and metabolic syndrome. Obesity Reviews 2018;19:557-75. [DOI: 10.1111/obr.12633] [Cited by in Crossref: 22] [Cited by in F6Publishing: 30] [Article Influence: 5.5] [Reference Citation Analysis]
30 Morley JE, Anker SD. Myopenia and precision (P4) medicine. J Cachexia Sarcopenia Muscle 2017;8:857-63. [PMID: 28944582 DOI: 10.1002/jcsm.12231] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
31 Han Y, Sun W, Sun G, Hou X, Gong Z, Xu J, Bai X, Fu L. A 3-year observation of testosterone deficiency in Chinese patients with chronic heart failure. Oncotarget 2017;8:79835-42. [PMID: 29108365 DOI: 10.18632/oncotarget.19816] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
32 von Haehling S, Ebner N, Dos Santos MR, Springer J, Anker SD. Muscle wasting and cachexia in heart failure: mechanisms and therapies. Nat Rev Cardiol. 2017;14:323-341. [PMID: 28436486 DOI: 10.1038/nrcardio.2017.51] [Cited by in Crossref: 134] [Cited by in F6Publishing: 156] [Article Influence: 26.8] [Reference Citation Analysis]
33 Alexander GC, Iyer G, Lucas E, Lin D, Singh S. Cardiovascular Risks of Exogenous Testosterone Use Among Men: A Systematic Review and Meta-Analysis. The American Journal of Medicine 2017;130:293-305. [DOI: 10.1016/j.amjmed.2016.09.017] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 13.2] [Reference Citation Analysis]
34 Kulej-Lyko K, Majda J, von Haehling S, Doehner W, Lopuszanska M, Szklarska A, Banasiak W, Anker SD, Ponikowski P, Jankowska EA. Could gonadal and adrenal androgen deficiencies contribute to the depressive symptoms in men with systolic heart failure? Aging Male 2016;19:221-30. [PMID: 27650467 DOI: 10.1080/13685538.2016.1208166] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
35 Collamati A, Marzetti E, Calvani R, Tosato M, D'Angelo E, Sisto AN, Landi F. Sarcopenia in heart failure: mechanisms and therapeutic strategies. J Geriatr Cardiol 2016;13:615-24. [PMID: 27605943 DOI: 10.11909/j.issn.1671-5411.2016.07.004] [Cited by in F6Publishing: 24] [Reference Citation Analysis]
36 De Spiegeleer A, Petrovic M, Boeckxstaens P, Van Den Noortgate N. Treating sarcopenia in clinical practice: where are we now? Acta Clin Belg 2016;71:197-205. [PMID: 27112427 DOI: 10.1080/17843286.2016.1168064] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
37 Sansone A, Sansone M, Lenzi A, Romanelli F. Testosterone Replacement Therapy: The Emperor's New Clothes. Rejuvenation Res 2017;20:9-14. [PMID: 27124096 DOI: 10.1089/rej.2016.1818] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
38 Wang W, Jiang T, Li C, Chen J, Cao K, Qi LW, Li P, Zhu W, Zhu B, Chen Y. Will testosterone replacement therapy become a new treatment of chronic heart failure? A review based on 8 clinical trials. J Thorac Dis 2016;8:E269-77. [PMID: 27162680 DOI: 10.21037/jtd.2016.03.39] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
39 Storer TW, Bhasin S, Travison TG, Pencina K, Miciek R, McKinnon J, Basaria S. Testosterone Attenuates Age-Related Fall in Aerobic Function in Mobility Limited Older Men With Low Testosterone. J Clin Endocrinol Metab 2016;101:2562-9. [PMID: 27050869 DOI: 10.1210/jc.2015-4333] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
40 Dos Santos MR, Sayegh AL, Bacurau AV, Arap MA, Brum PC, Pereira RM, Takayama L, Barretto AC, Negrão CE, Alves MJ. Effect of Exercise Training and Testosterone Replacement on Skeletal Muscle Wasting in Patients With Heart Failure With Testosterone Deficiency. Mayo Clin Proc 2016;91:575-86. [PMID: 27040087 DOI: 10.1016/j.mayocp.2016.02.014] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
41 Arcopinto M, Salzano A, Isgaard J, Cittadini A. Hormone replacement therapy in heart failure. Curr Opin Cardiol 2015;30:277-84. [PMID: 25807222 DOI: 10.1097/HCO.0000000000000166] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
42 Morales A, Bebb RA, Manjoo P, Assimakopoulos P, Axler J, Collier C, Elliott S, Goldenberg L, Gottesman I, Grober ED, Guyatt GH, Holmes DT, Lee JC; Canadian Men’s Health Foundation Multidisciplinary Guidelines Task Force on Testosterone Deficiency. Diagnosis and management of testosterone deficiency syndrome in men: clinical practice guideline. CMAJ 2015;187:1369-77. [PMID: 26504097 DOI: 10.1503/cmaj.150033] [Cited by in Crossref: 53] [Cited by in F6Publishing: 62] [Article Influence: 7.6] [Reference Citation Analysis]
43 Seftel AD, Kathrins M, Niederberger C. Critical Update of the 2010 Endocrine Society Clinical Practice Guidelines for Male Hypogonadism. Mayo Clinic Proceedings 2015;90:1104-15. [DOI: 10.1016/j.mayocp.2015.06.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 5.9] [Reference Citation Analysis]
44 Dean JD, Mcmahon CG, Guay AT, Morgentaler A, Althof SE, Becher EF, Bivalacqua TJ, Burnett AL, Buvat J, El Meliegy A, Hellstrom WJ, Jannini EA, Maggi M, Mccullough A, Torres LO, Zitzmann M. The International Society for Sexual Medicine's Process of Care for the Assessment and Management of Testosterone Deficiency in Adult Men. The Journal of Sexual Medicine 2015;12:1660-86. [DOI: 10.1111/jsm.12952] [Cited by in Crossref: 78] [Cited by in F6Publishing: 66] [Article Influence: 11.1] [Reference Citation Analysis]
45 Santos MR, Sayegh AL, Groehs RV, Fonseca G, Trombetta IC, Barretto AC, Arap MA, Negrão CE, Middlekauff HR, Alves MJ. Testosterone deficiency increases hospital readmission and mortality rates in male patients with heart failure. Arq Bras Cardiol 2015;105:256-64. [PMID: 26200897 DOI: 10.5935/abc.20150078] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
46 Morley JE. Pharmacologic Options for the Treatment of Sarcopenia. Calcif Tissue Int 2016;98:319-33. [DOI: 10.1007/s00223-015-0022-5] [Cited by in Crossref: 110] [Cited by in F6Publishing: 114] [Article Influence: 15.7] [Reference Citation Analysis]
47 Borst SE, Yarrow JF. Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men. Am J Physiol Endocrinol Metab 2015;308:E1035-42. [PMID: 25898953 DOI: 10.1152/ajpendo.00111.2015] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 5.7] [Reference Citation Analysis]
48 Morgentaler A, Miner MM, Caliber M, Guay AT, Khera M, Traish AM. Testosterone therapy and cardiovascular risk: advances and controversies. Mayo Clin Proc 2015;90:224-51. [PMID: 25636998 DOI: 10.1016/j.mayocp.2014.10.011] [Cited by in Crossref: 110] [Cited by in F6Publishing: 105] [Article Influence: 15.7] [Reference Citation Analysis]
49 Maggio M, Lauretani F, De Vita F, Basaria S, Lippi G, Butto V, Luci M, Cattabiani C, Ceresini G, Verzicco I, Ferrucci L, Ceda GP. Multiple hormonal dysregulation as determinant of low physical performance and mobility in older persons. Curr Pharm Des 2014;20:3119-48. [PMID: 24050169 DOI: 10.2174/13816128113196660062] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
50 Lavie CJ, De Schutter A, Alpert MA, Mehra MR, Milani RV, Ventura HO. Obesity paradox, cachexia, frailty, and heart failure. Heart Fail Clin 2014;10:319-26. [PMID: 24656108 DOI: 10.1016/j.hfc.2013.12.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
51 Borst SE, Shuster JJ, Zou B, Ye F, Jia H, Wokhlu A, Yarrow JF. Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis. BMC Med 2014;12:211. [PMID: 25428524 DOI: 10.1186/s12916-014-0211-5] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 9.4] [Reference Citation Analysis]
52 Traish AM. Outcomes of testosterone therapy in men with testosterone deficiency (TD): Part II. Steroids 2014;88:117-26. [DOI: 10.1016/j.steroids.2014.05.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
53 Traish AM. Adverse health effects of testosterone deficiency (TD) in men. Steroids 2014;88:106-16. [DOI: 10.1016/j.steroids.2014.05.010] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
54 Momosaki R, Abo M, Watanabe S, Kakuda W, Yamada N, Mochio K. Effects of testosterone levels on functional recovery with rehabilitation in stroke patients. Neurol Med Chir (Tokyo) 2014;54:794-8. [PMID: 25263622 DOI: 10.2176/nmc.oa.2014-0078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
55 Traish AM, Guay AT, Morgentaler A. Death by testosterone? We think not! J Sex Med. 2014;11:624-629. [PMID: 24589170 DOI: 10.1111/jsm.12464] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
56 Mirdamadi A, Garakyaraghi M, Pourmoghaddas A, Bahmani A, Mahmoudi H, Gharipour M. Beneficial effects of testosterone therapy on functional capacity, cardiovascular parameters, and quality of life in patients with congestive heart failure. Biomed Res Int 2014;2014:392432. [PMID: 25110677 DOI: 10.1155/2014/392432] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
57 Morgentaler A. Testosterone, cardiovascular risk, and hormonophobia. J Sex Med. 2014;11:1362-1366. [PMID: 24787518 DOI: 10.1111/jsm.12556] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
58 Morley J. Is it possible to prevent injurious falls? European Geriatric Medicine 2014;5:75-7. [DOI: 10.1016/j.eurger.2014.01.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
59 Su JJ, Park SK, Hsieh TM. The Effect of Testosterone on Cardiovascular Disease: A Critical Review of the Literature. Am J Mens Health 2014;8:470-91. [DOI: 10.1177/1557988314522642] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
60 Morley JE, Malmstrom TK. Frailty, sarcopenia, and hormones. Endocrinol Metab Clin North Am 2013;42:391-405. [PMID: 23702408 DOI: 10.1016/j.ecl.2013.02.006] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 9.5] [Reference Citation Analysis]
61 Tzanis G, Dimopoulos S, Agapitou V, Nanas S. Exercise Intolerance in Chronic Heart Failure: The Role of Cortisol and the Catabolic State. Curr Heart Fail Rep 2014;11:70-9. [DOI: 10.1007/s11897-013-0177-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
62 Mehra MR. Fat, Cachexia, and the Right Ventricle in Heart Failure. Journal of the American College of Cardiology 2013;62:1671-3. [DOI: 10.1016/j.jacc.2013.07.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
63 von Haehling S, Anker SD, Doehner W, Morley JE, Vellas B. Frailty and heart disease. International Journal of Cardiology 2013;168:1745-7. [DOI: 10.1016/j.ijcard.2013.07.068] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 6.1] [Reference Citation Analysis]
64 Bušić Z, Culić V. Testosterone treatment and exercise capacity. Am Heart J 2013;166:e21. [PMID: 24093863 DOI: 10.1016/j.ahj.2013.07.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]